More Business Briefs
- Business briefs: Pfizer, Novartis, Boehringer Ingelheim, Elsevier
- Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman
- Business briefs: Actavis, Bayer, Oramed, Elan
- Business briefs: Pfizer, BMS, CMS, Sanofi
- Business briefs: Bayer, FDA, Ranbaxy
Chandler Chicco Companies announced June 6 that it is adding a new division. The marketing agency, which is part of inVentiv Health, is consolidating its digital strategy unit with the recently acquired Kazaam Interactive. The new entity, named Chandler Chicco Digital, will provide integrated social and digital programs and offer service that include website development and hosting, CRM integration and mobile app development. “Kazaam and CCC have healthcare at their core,” Kazaam's CEO Tom Marotta said in a statement.
Two months after supporting a “breach of trusts” procedure the European Medicines Agency approves a set of rules for how to deal with board members who incorrectly report or downplay their affiliations. This procedure complements its March 2012 policy which for identifying potential conflicts of interest. The EMA requires staff and agency members to provide declarations of interest annually. It also assigns risk levels for potential committee members after examining an annual form in which experts indicate the nature of their interests, the duration and the type of activity the expert may undertake on behalf of the EMA.